Promote Sponsor
verified SJR 7,458 · Q1 • database Scopus / SJR & Web of Science indexed
The Lancet Psychiatry
United Kingdom · Elsevier Ltd
workspace_premium Q1 — Psychiatry and Mental Health lock Subscription Unclaimed

The Lancet Psychiatry

The Lancet Psychiatry is a journal indexed in SJR in Psychiatry and Mental Health and Biological Psychiatry with an H index of 160. It has an SJR impact factor of 7,458 and it has a best quartile of Q1. It has an SJR impact factor of 7,458.

The Lancet Psychiatry focuses its scope in these topics and keywords: mental, randomised, symptoms, thinking, controlled, health, perinatal, depressive, depression, association, ...

ISSN: 2215-0366
Editorial: Elsevier Ltd
Category: Psychiatry and Mental Health
Indexation: verifiedScopus / SJR verifiedWeb of Science

Unclaimed profile — some fields may be incomplete.

open_in_new Portal NPD menu_book Guidelines NPD
schedule Datos CoP · solo campos en BD
SJR Impact Factor trending_up
7,458 Q1
H-index 160
Tasa de Aceptación pie_chart
24% Selectiva
Fuente Acceptance_Rate
Tiempo a publicación hourglass_top
NPD
Campo Sin dato
Coste de Publicación (APC) payments
NPD Subscription
Ruta Non-OA NPD

Metrics

Campos Scimago / CoP — sin series inventadas

Scopus / SJR Web of Science

SJR Impact

7,458

H-index

160

Docs (year)

241

Docs 3y

764

Total refs

4884

Cites 3y

6006

Citable 3y

280

Cites/Doc 2y

7.51

Ref/Doc

20.27

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Crucial need to improve mental health research and training for human rights advocates

View more

What's in a name?

View more

Gitte Knudsen: broadening the mind

View more

Former Armed Forces personnel in the Criminal Justice System

View more

Fool's gold

View more

Experimental psychopathology should not be examined with rose-tinted glasses

View more

Esketamine as a treatment for paediatric depression: questions of safety and efficacy

View more

Enough talk: fighting stigma in mental health

View more

Elucidating postpartum depression through statistics

View more

Drawn from memory

View more

Do we need to talk?

View more

Diagnosis: one useful method among many

View more
SHOW MORE ARTICLES

Depression: an economic and moral case to tackle the crisis

View more

A level playing field

View more

Cost-effectiveness of care for people with psychosis in the community and psychiatric hospitals in the Czech Republic: an economic analysis

View more

Control of fentanyl-related substances in China

View more

Considering new insights into antisociality and psychopathy

View more

Cognitive and brain reserve and the risk of postoperative delirium in older patients: analysis of data from a prospective observational study

View more

Clinical risk prediction in schizophrenia

View more

Broken promises: indigenous peoples' mental health in South America

View more

Breastfeeding and lithium: is breast always best?

View more

Bipolar treatment efficacy -Authors' reply

View more

Bipolar treatment efficacy

View more

Associations of mental distress with residency in conflict zones, ethnic minority status, and potentially modifiable social factors following conflict in Sri Lanka: a nationwide cross-sectional study

View more

FAQS